Cellular suicide switch discovered

December 4, 2013
Cell biology: Taking advantage of defects in splicing
Relative to a normal brain (top), the brains of mice lacking the Prmt5 gene are underdeveloped and lack key structural components (bottom). Credit: M. Bezzi, et al.

A newly discovered early-warning system triggers cellular suicide when a critical RNA editing system breaks down.

The initial RNA transcript generated from a given gene is only a first draft that must be heavily edited before it is translated. This process entails splicing together segments of the RNA—known as 'exons'—that actually encode a protein product, while removing the noncoding 'intron' sequences that lie between the exons. Improper splicing results in proteins that are defective or entirely nonfunctional. Now, research from Ernesto Guccione's team at the A*STAR Institute of Molecular and Cell Biology in Singapore has uncovered a splicing 'quality-control system' that could also offer a mechanism for fighting cancer.

Guccione and co-workers began by studying the function of protein arginine methyltransferase 5 (PRMT5), an enzyme that introduces chemical modifications onto other proteins. Because PRMT5 is known to act within the brain, the researchers generated transgenic mice that no longer produced this protein in their . These animals died within weeks of birth, with profound neurological defects and apparent disruption of brain development.

Careful examination of cultured neuronal precursor cells showed that the absence of PRMT5 triggered a cellular 'self-destruct' mechanism known as . This process was mediated in part by p53, a protein that acts as a critical safeguard against cancer by triggering apoptosis in cells on the verge of .

Several components of the cellular splicing machinery are among PRMT5's targets. Guccione and co-workers determined that the increased apoptosis observed in the absence of PRMT5 was a direct result of splicing defects. Without the chemical modifications introduced by PRMT5, the splicing proteins failed to assemble properly. The researchers identified hundreds of genes from PRMT5-deficient cells in which introns had been retained or exons had been inappropriately eliminated.

Among the affected proteins was MDM4, a protein that inhibits p53, thus preventing apoptosis and facilitating tumor formation. In the absence of PRMT5, the RNA encoding MDM4 loses an exon, yielding a truncated and unstable product that is no longer able to block p53-mediated apoptosis.

This vulnerability to mis-splicing turns Mdm4 into an important quality-control system. "We have identified a 'sensing mechanism' that directly links defects in the splicing machinery to activation of the p53 pathway," says Guccione. This mechanism is also present in human cells. His group sees great potential in deliberately tripping the MDM4 sensor system as a means to selectively kill cancer cells. "We have already obtained very promising initial results both in cell lines and in mouse models," he says.

Explore further: New mechanism in the regulation of human genes

More information: Bezzi, M., Teo, S. X., Muller, J., Mok, W. C., Sahu, S. K. et al. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes & Development 27, 1903–1916 (2013).

Related Stories

New mechanism in the regulation of human genes

July 14, 2011
Scientists at the Technical University of Munich and the Helmholtz Zentrum Muenchen and along with their colleagues from the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Centre for Genomic Regulation ...

Recommended for you

The 16 genetic markers that can cut a life story short

July 27, 2017
The answer to how long each of us will live is partly encoded in our genome. Researchers have identified 16 genetic markers associated with a decreased lifespan, including 14 new to science. This is the largest set of markers ...

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.